DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis

Loss of DAB2IP, a novel tumor suppressor gene, is associated with the high risk of aggressive prostate cancer (PCa). Previously, we reported that DAB2IP modulated androgen receptor activation in the development of castration-resistant PCa; however, its direct action on the failure of androgen depriv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Zhou, J, Ning, Z, Wang, B, Yun, E-J, Zhang, T, Pong, R-C, Fazli, L, Gleave, M, Zeng, J, Fan, J, Wang, X, Li, L, Hsieh, J-T, He, D, Wu, K
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5399177/
https://ncbi.nlm.nih.gov/pubmed/26512963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2015.289
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados